But it also left open a number of exceptions – including for law enforcement – and did not affect private companies. These ...

A Ronald Reagan appointee pressed the customers on their standing and supposed injury suffered from having their voiceprints ...

Chinese entities have been acquiring land in key locations near U.S. military bases, sparking national security concerns about possible spying — or even a potential attack. Former national security ...

The US Securities and Exchange Commission is investigating AppLovin's data collection practices following allegations that it violated service agreements to serve targeted adverts to users. As ...

Oct 6 (Reuters) - The U.S. Securities and Exchange Commission has been probing marketing platform AppLovin's (APP.O), opens new tab data-collection practices, Bloomberg News reported on Monday, citing ...

Servers in a data center in 2015. The data-center economy is booming in California, and Gov. Gavin Newsom doesn’t want to slow it down. The governor vetoed a bill on Saturday that would have provided ...

"Directions to 255 USA Parkway," Brian Armon asked his phone's AI assistant, which responded with a virtual map and a traffic report. Armon, a commercial real estate broker, was driving to the Tahoe ...

This is read by an automated voice. Please report any issues or inconsistencies here. Gov. Gavin Newsom vetoed a bill that would have tracked data centers’ growing water footprint in California. He ...

The Online Data Privacy Act, or MODPA, bans the sale of sensitive data such as gender, race and citizenship status — the first state to do so.

AppLovin Corp (NASDAQ:APP) slumped Monday afternoon after Bloomberg reported the SEC is probing the mobile ad-tech firm's data-collection practices, including possible breaches of partners' service ...

California’s pay data reporting rules are now more burdensome. Senate Bill 464, signed into law on October 13, 2025, enhances ...

Moderna has shared some of the phase 1/2 data that persuaded it to expand and prioritize development of a cancer candidate, reporting responses in melanoma patients failed by checkpoint inhibitors.